Oklahoma Cannabis Regulator Wins Case Against a Fraudulent Cannabis Business
Oklahoma’s cannabis regulator has denied a business application to a company following a judge’s ruling that the business submitted fraudulent ownership information.
Cannabis Helps Woman to Reduce Medication Use for Nerve Pain, Case Study Reports
The case study follows a 61-year-old woman who was able to significantly reduce the dose of prescription medication she was taking to control her neuropathic pain after being prescribed a THC-containing cannabis oil.
Colorado Regulator Issues Two New Warnings About Moldy Cannabis Products
State regulators in Colorado have issued two more health and safety notices after “potentially unsafe levels” of total yeast and mold and Aspergillus were found in certain pre-roll cigarettes and batches of cannabis flower.
Tackling Cannabis Facility Design with Urban-Gro
To learn more about the services that are available to new cultivators setting up shop, Analytical Cannabis spoke with Arie Kamp, managing director at urban-gro Europe, a leading architectural and engineering firm that is already applying its design-build expertise to the cannabis industry.
An Update on Synthetic Cannabinoid Research
Kenneth B. Walsh, a professor of pharmacology, physiology, and neuroscience at the University of South Carolina, updates us on the latest research from the world of synthetic cannabinoid receptor agonists.
How Controlling Cannabis Genetics Can Boost Crops
Mark Lewis, president of Napro Research, outlines how genetics can be harnessed to secure the future of cannabis.
Researchers Discover New Mechanism of Psychedelic Action in the Brain
The findings could explain why the effects of psychedelics, such as neuroplasticity and even antidepressant action, vary between different drugs.
Australia to Permit MDMA and Psilocybin Prescriptions
From July 1, psychiatrists in Australia will be allowed to prescribe MDMA and psilocybin as treatments for certain mental health conditions.
